These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 14961590

  • 1. Lack of mutation of the folliculin gene in sporadic chromophobe renal cell carcinoma and renal oncocytoma.
    Nagy A, Zoubakov D, Stupar Z, Kovacs G.
    Int J Cancer; 2004 Apr 10; 109(3):472-5. PubMed ID: 14961590
    [Abstract] [Full Text] [Related]

  • 2. Microsatellite allelotyping differentiates chromophobe renal cell carcinomas from renal oncocytomas and identifies new genetic changes.
    Nagy A, Buzogany I, Kovacs G.
    Histopathology; 2004 Jun 10; 44(6):542-6. PubMed ID: 15186268
    [Abstract] [Full Text] [Related]

  • 3. Inactivation of BHD in sporadic renal tumors.
    Khoo SK, Kahnoski K, Sugimura J, Petillo D, Chen J, Shockley K, Ludlow J, Knapp R, Giraud S, Richard S, Nordenskjöld M, Teh BT.
    Cancer Res; 2003 Aug 01; 63(15):4583-7. PubMed ID: 12907635
    [Abstract] [Full Text] [Related]

  • 4. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L, Sugimura J, Tretiakova MS, Patton KT, Gupta R, Popov B, Laskin WB, Yeldandi A, Teh BT, Yang XJ.
    Hum Pathol; 2005 Mar 01; 36(3):262-8. PubMed ID: 15791570
    [Abstract] [Full Text] [Related]

  • 5. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
    Petersson F, Gatalica Z, Grossmann P, Perez Montiel MD, Alvarado Cabrero I, Bulimbasic S, Swatek A, Straka L, Tichy T, Hora M, Kuroda N, Legendre B, Michal M, Hes O.
    Virchows Arch; 2010 Apr 01; 456(4):355-65. PubMed ID: 20300772
    [Abstract] [Full Text] [Related]

  • 6. Frequent allelic changes at chromosome 7q34 but lack of mutation of the BRAF in papillary renal cell tumors.
    Nagy A, Balint I, Kovacs G.
    Int J Cancer; 2003 Oct 10; 106(6):980-1. PubMed ID: 12918080
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC, Chen PC, Chiang H.
    Am J Clin Pathol; 2004 Jun 10; 121(6):878-83. PubMed ID: 15198361
    [Abstract] [Full Text] [Related]

  • 8. Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas.
    Herbers J, Schullerus D, Chudek J, Bugert P, Kanamaru H, Zeisler J, Ljungberg B, Akhtar M, Kovacs G.
    J Pathol; 1998 Jan 10; 184(1):58-62. PubMed ID: 9582528
    [Abstract] [Full Text] [Related]

  • 9. Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens.
    Zhuang Z, Gnarra JR, Dudley CF, Zbar B, Linehan WM, Lubensky IA.
    Mod Pathol; 1996 Aug 10; 9(8):838-42. PubMed ID: 8871925
    [Abstract] [Full Text] [Related]

  • 10. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
    Kato I, Iribe Y, Nagashima Y, Kuroda N, Tanaka R, Nakatani Y, Hasumi H, Yao M, Furuya M.
    Hum Pathol; 2016 Jun 10; 52():74-82. PubMed ID: 26980015
    [Abstract] [Full Text] [Related]

  • 11. Mutation of the p53 tumour suppressor gene occurs preferentially in the chromophobe type of renal cell tumour.
    Contractor H, Zariwala M, Bugert P, Zeisler J, Kovacs G.
    J Pathol; 1997 Feb 10; 181(2):136-9. PubMed ID: 9120715
    [Abstract] [Full Text] [Related]

  • 12. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF, Winterpacht A, Störkel S, Brenner W, Hohenfellner R, Zabel B, Huber C, Decker HJ.
    Cancer Res; 1997 Nov 15; 57(22):5009-12. PubMed ID: 9371493
    [Abstract] [Full Text] [Related]

  • 13. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
    Furuya M, Hong SB, Tanaka R, Kuroda N, Nagashima Y, Nagahama K, Suyama T, Yao M, Nakatani Y.
    Cancer Sci; 2015 Mar 15; 106(3):315-23. PubMed ID: 25594584
    [Abstract] [Full Text] [Related]

  • 14. Genome-Wide Uniparental Disomy and Copy Number Variations in Renal Cell Carcinomas Associated with Birt-Hogg-Dubé Syndrome.
    Iribe Y, Yao M, Tanaka R, Kuroda N, Nagashima Y, Nakatani Y, Furuya M.
    Am J Pathol; 2016 Feb 15; 186(2):337-46. PubMed ID: 26776076
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP, Papavero V, Sugimura J, Teh BT, Yang XJ.
    Anal Quant Cytol Histol; 2006 Aug 15; 28(4):228-36. PubMed ID: 16927643
    [Abstract] [Full Text] [Related]

  • 16. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
    Adley BP, Gupta A, Lin F, Luan C, Teh BT, Yang XJ.
    Am J Clin Pathol; 2006 Jul 15; 126(1):79-85. PubMed ID: 16753598
    [Abstract] [Full Text] [Related]

  • 17. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC, Walsh S, Hewson K, Green EK, Brinke A, Green PM, Gianelli F, Eng C, Maher ER.
    Genes Chromosomes Cancer; 1999 Sep 15; 26(1):20-8. PubMed ID: 10441001
    [Abstract] [Full Text] [Related]

  • 18. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome.
    Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS.
    Cancer Cell; 2002 Aug 15; 2(2):157-64. PubMed ID: 12204536
    [Abstract] [Full Text] [Related]

  • 19. Eosinophilic and classic chromophobe renal cell carcinomas have similar frequent losses of multiple chromosomes from among chromosomes 1, 2, 6, 10, and 17, and this pattern of genetic abnormality is not present in renal oncocytoma.
    Brunelli M, Eble JN, Zhang S, Martignoni G, Delahunt B, Cheng L.
    Mod Pathol; 2005 Feb 15; 18(2):161-9. PubMed ID: 15467713
    [Abstract] [Full Text] [Related]

  • 20. High-resolution DNA copy number and gene expression analyses distinguish chromophobe renal cell carcinomas and renal oncocytomas.
    Yusenko MV, Kuiper RP, Boethe T, Ljungberg B, van Kessel AG, Kovacs G.
    BMC Cancer; 2009 May 18; 9():152. PubMed ID: 19445733
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.